title: Consecutive use of different biological therapies in the treatment of psoriasis.
authors.forename: A
authors.initials: A
authors.lastname: Costanzo
authors.forename: M
authors.initials: M
authors.lastname: Papoutsaki
authors.forename: A
authors.initials: A
authors.lastname: Mazzotta
authors.forename: S
authors.initials: S
authors.lastname: Chimenti
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003879:Dermatologic Agents / Q000627:therapeutic use*; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069285:Infliximab; D011565:Psoriasis / Q000188:drug therapy*; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept